RFC
LSTA icon

Regions Financial Corp’s Lisata Therapeutics LSTA Stock Holding History

Regions Financial Corp’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-149
Closed -$8K – 1335
2019
Q1 		$8K Hold
149
– – ﹤0.01% 1582
2018
Q4 		$8K Hold
149
– – ﹤0.01% 1560
2018
Q3 		$13K Buy
149
+2
+1% +$164 ﹤0.01% 1564
2018
Q2 		$14K Hold
147
– – ﹤0.01% 1555
2018
Q1 		$13K Hold
147
– – ﹤0.01% 1579
2017
Q4 		$8K Buy
+147
New +$7.38K ﹤0.01% 1726

Other funds holding LSTA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $3.61B AUM 24.09% 1-Year Est. Return

Regions Financial Corp's LSTA Position: Q2 2019 in Review

Regions Financial Corp sold out of Lisata Therapeutics (LSTA) in Q2 2019, closing a stake of 149 shares — an estimated $8K sold.

Regions Financial Corp first reported a position in LSTA in Q4 2017 and held it in 6 quarters. The position peaked at $14K in Q2 2018. 26 funds tracked by Wall St. Rank hold LSTA as of Q2 2019.

  • Regions Financial Corp reported no remaining Lisata Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Regions Financial Corp sold 149 Lisata Therapeutics shares in Q2 2019, an estimated $8K.
  • Regions Financial Corp first reported a position in Lisata Therapeutics in Q4 2017 and held it in 6 quarters.
  • Regions Financial Corp's Lisata Therapeutics position peaked at $14K in Q2 2018.
  • 26 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2019.

Based on Regions Financial Corp's 13F filing for Q2 2019, filed 19 Jul 2019.